NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...
The weekly report from the Arkansas Department of Health shows flu activity at a very high level for the week ending Feb. 1.
Data from the Centers from Disease Control and Prevention on doctors' visits for flu-like symptoms indicate this is the most ...
An infectious disease MD explains for how long you're likely to transmit the flu to others, with her advice for preventing ...
Because of the high number of flu patients being prescribed this drug, some pharmacies are experiencing a shortage. According ...
Management reiterated its full-year revenue target of JPY460 billion and emphasized achieving JPY550 billion in FY2025. Growth is expected from the HIV franchise, global expansion of Xocova, and ...
Godley, Comanche, Euless schools closed after increased flu-relate absences from students, staff, using time to sanitize ...
NanoViricides, Inc. (NYSE American: NNVC) presented its latest advancements at the MicroCap <a target=_blank href= ...
SHELTON, CT / ACCESS Newswire / January 27, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today announced that it has engaged a Clinical Research Organization (CRO) to conduct a ...
Vaccines, antibodies, and small chemical drugs such as tecovirimat for MPox/Smallpox, or oseltamivir (Tamiflu®), baloxavir (Xofluza®) for Influenza are readily escaped by viruses wirth small changes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback